SCHEMBL4388697

SCHEMBL4388697

O=CC(CCC(=O)N1CCN(C2CCCC2)CC1)c1ccccc1

nearest known ligand 0.57

Predicted protein targets (top 11)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 6/20 0.56
ALDH1A1 P00352 5/20 0.56
CHRM1 P11229 2/20 0.50
MAPT P10636 1/20 0.48
HIF1A Q16665 1/20 0.48
HRH3 Q9Y5N1 8/20 0.48
POLB P06746 1/20 0.47
TSHR P16473 2/20 0.46
KMT2A Q03164 1/20 0.46
KCNH2 Q12809 1/20 0.45
GAA P10253 1/20 0.45

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Hydrochloric Acid SCHEMBL4380646 0.99 KDM4E (0.55) KDM4EALDH1A1CHRM1MAPTHIF1A
SCHEMBL3859810 0.77 KDM4E (0.64) KDM4EALDH1A1CHRM1POLB
SCHEMBL4377352 0.75 HRH3 (0.76) KDM4EALDH1A1MAPTHIF1AHRH3
Hydrochloric Acid SCHEMBL4377272 0.74 HRH3 (0.77) KDM4EALDH1A1MAPTHIF1AHRH3
SCHEMBL13636480 0.73 HRH3 (0.65) KDM4EALDH1A1MAPTHIF1AHRH3
SCHEMBL16705050 0.72 KDM4E (0.57) KDM4EALDH1A1CHRM1HRH3POLB
SCHEMBL469112 0.72 KDM4E (0.57) KDM4EALDH1A1CHRM1HRH3POLB
SCHEMBL4375964 0.72 HRH3 (0.65) KDM4EALDH1A1CHRM1HRH3TSHR
SCHEMBL13004966 0.71 NPSR1 (0.67) KDM4EALDH1A1KMT2AGAA
Hydrochloric Acid SCHEMBL4375732 0.71 HRH3 (0.65) KDM4EALDH1A1CHRM1HRH3TSHR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1421071-B1 SUBSTITUTED PIPERAZINE AND DIAZEPANE DERIVAIVES AS HISTAMINE H3 RECEPTOR MODULATORS HIGH POINT PHARMACEUTICALS LLC (US) 2009-11-18 EP claimed
EP-1421071-B1 SUBSTITUTED PIPERAZINE AND DIAZEPANE DERIVAIVES AS HISTAMINE H3 RECEPTOR MODULATORS HIGH POINT PHARMACEUTICALS LLC (US) 2009-11-18 EP disclosed